Securities Registration (section 12(b)) (8-a12b)
June 22 2017 - 5:01PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF
SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF
THE
SECURITIES EXCHANGE ACT OF 1934
Checkpoint Therapeutics, Inc.
(Exact name of registrant as specified
in its charter)
Delaware
(State of incorporation or organization)
|
47-2568632
(I.R.S. Employer Identification No.)
|
2 Gansevoort Street, 9
th
Floor,
New York, New York 10014
(Address and Zip Code of Principal Executive
Offices)
Securities to be registered pursuant to Section 12(b) of the
Act:
Title of each class
to be so registered
Common Stock, par value $0.0001 per share
|
Name of each exchange on which
each class is to be registered
The NASDAQ Stock Market LLC
|
If this form relates to the registration
of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c),
please check the following box. ☒
|
|
If this form relates to the registration
of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d),
please check the following box. ☐
|
Securities Act registration statement file number to which this
form relates:
000-55506
Securities to be registered pursuant to Section 12(g) of the
Act: None
Item 1. Description
of Registrant’s Securities to be Registered.
The description of the common stock, par
value $0.0001 per share, of Checkpoint Therapeutics, Inc. (the “Registrant”),
as
included under the caption “Description of Registrant’s Securities to be Registered” in the Registration Statement
on Form 10, as amended, originally filed with the Securities and Exchange Commission (the “Commission”) on July 11,
2016 (Registration No. 000-55506), including exhibits, and as subsequently amended from time to time (the “Registration Statement”),
is hereby incorporated by reference. Capitalized terms used herein and not otherwise defined shall have the meanings assigned to
them in the Registration Statement
.
The Registrant’s common stock to
be registered hereunder has been approved for listing on The NASDAQ Capital Market of The NASDAQ Stock Market LLC under the symbol
“CKPT.”
Item 2. Exhibits.
Under
the Instructions as to Exhibits with respect to Form 8-A, no exhibits are required to be filed because no other securities of the
Registrant are registered on The NASDAQ Stock Market LLC and the securities registered hereby are not being registered pursuant
to Section 12(g) of the Exchange Act.
SIGNATURE
Pursuant to the requirements of Section
12 of the Securities Exchange Act of 1934, the Registrant has duly caused this registration statement to be signed on its behalf
by the undersigned, thereto duly authorized.
|
Checkpoint Therapeutics, Inc.
|
|
|
|
|
Date: June 22, 2017
|
By:
|
/s/ James F. Oliviero
|
|
|
Name:
|
James F. Oliviero
|
|
|
Title:
|
President and Chief Executive Officer
|
|